Consolidated Balance Sheets - USD ($)	Jun. 30, 2018	Jun. 30, 2017
Current Assets:
Cash	$ 14,892,439	$ 14,054,006
Receivables, net allowance for doubtful accounts of $153,220 and $392,250 at June 30, 2018 and 2017, respectively	7,724,635	4,009,127
Prepaid expense and other current assets	1,116,387	643,600
Total current assets	23,733,461	18,706,733
Property and equipment, net	1,896,348	2,115,277
Other Assets:
Long-term receivables, deposits and other assets	1,213,265	2,540,291
Investments	477,884	477,884
Customer relationships	919,800	1,051,200
Goodwill	20,883,886	20,883,886
Capitalized software costs, net	168,926	137,205
Total other assets	23,663,761	25,090,466
Total assets	49,293,570	45,912,476
Current liabilities:
Accounts payable	1,490,434	565,487
Accrued liabilities	745,694	2,084,980
Deferred revenue	2,335,286	2,350,846
Line of credit	3,230,000	2,850,000
Current portion of notes payable	188,478	318,616
Total current liabilities	7,989,892	8,169,929
Long-term liabilities:
Notes payable, less current portion	1,592,077	1,996,953
Other long-term liabilities	7,275	36,743
Total liabilities	9,589,244	10,203,625
Commitments and contingencies
Stockholders' equity:
Common stock, $0.01 par value, 50,000,000 shares authorized; 19,773,549 and 19,423,821 issued and outstanding at June 30, 2018 and 2017, respectively	197,738	194,241
Additional paid-in capital	76,711,887	75,489,189
Accumulated deficit	(37,213,677)	(39,983,692)
Total stockholders' equity	39,704,326	35,708,851
Total liabilities and stockholders' equity	49,293,570	45,912,476
Series B Preferred [Member]
Stockholders' equity:
Preferred stock; $0.01 par value, 30,000,000 shares authorized; Series B Preferred, 700,000 shares authorized; 625,375 issued and outstanding at June 30, 2018 and 2017; Series B-1 Preferred, 550,000 shares authorized; 212,402 and 285,859 shares issued and outstanding at June 30, 2018 and 2017, respectively	6,254	6,254
Series B-1 Preferred [Member]
Stockholders' equity:
Preferred stock; $0.01 par value, 30,000,000 shares authorized; Series B Preferred, 700,000 shares authorized; 625,375 issued and outstanding at June 30, 2018 and 2017; Series B-1 Preferred, 550,000 shares authorized; 212,402 and 285,859 shares issued and outstanding at June 30, 2018 and 2017, respectively	$ 2,124	$ 2,859